NCT00251992

Nexium Dyspepsia/AST

Supportive Test for Acid-Related Symptoms (STARS II) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Uninvestigated Subjects With Upper Gastrointestinal Symptoms.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,200 (planned)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

The aim is to evaluate if the resolution of upper abdominal symptoms (pain or burning) during an acid suppressive test trial of esomprazole given daily for 7 days predicts symptoms resolution at the end of a subsequent treatment period of 7 weeks.

Conditions

• Gastrointestinal Disease
• Signs and Symptoms, Digestive
• Dyspepsia

Interventions

Type	Name	Description
DRUG	Esomeprazole

Timeline

• Start date: 2002-12-01
• Primary completion: 2005-01-01
• Completion: 2005-01-01
• First posted: 2005-11-11
• Last updated: 2011-01-24

Locations

183 sites across 13 countries: Austria, Belgium, Canada, Finland, France, Germany, Hungary, Mexico, Norway, South Africa, Sweden, Switzerland, United Kingdom